These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 30078389

  • 21. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
    Birdwell LD, Zalinger ZB, Li Y, Wright PW, Elliott R, Rose KM, Silverman RH, Weiss SR.
    J Virol; 2016 Jan 06; 90(6):3160-72. PubMed ID: 26739051
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication.
    Zhou X, Tian L, Wang J, Zheng B, Zhang W.
    Virol Sin; 2022 Jun 06; 37(3):418-426. PubMed ID: 35504537
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells.
    Yan K, Zhu W, Yu L, Li N, Zhang X, Liu P, Chen Q, Chen Y, Han D.
    Mol Cell Endocrinol; 2013 Jun 15; 372(1-2):73-85. PubMed ID: 23567548
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family.
    Torices S, Teglas T, Naranjo O, Fattakhov N, Frydlova K, Cabrera R, Osborne OM, Sun E, Kluttz A, Toborek M.
    Mol Neurobiol; 2023 Sep 15; 60(9):4966-4982. PubMed ID: 37209263
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Differential regulation of the OASL and OAS1 genes in response to viral infections.
    Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR, Hartmann R.
    J Interferon Cytokine Res; 2009 Apr 15; 29(4):199-207. PubMed ID: 19203244
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.
    Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R.
    J Interferon Cytokine Res; 2011 Jan 15; 31(1):41-7. PubMed ID: 21142819
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression.
    Kulka M, Calvo MS, Ngo DT, Wales SQ, Goswami BB.
    Virology; 2009 May 25; 388(1):169-84. PubMed ID: 19383565
    [Abstract] [Full Text] [Related]

  • 39. Evolution of the 2'-5'-oligoadenylate synthetase family in eukaryotes and bacteria.
    Kjaer KH, Poulsen JB, Reintamm T, Saby E, Martensen PM, Kelve M, Justesen J.
    J Mol Evol; 2009 Dec 25; 69(6):612-24. PubMed ID: 19904482
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.